Response to Comment on: Selvin et al. No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes. Diabetes Care 2013;36:2995–30...

Por Selvin, Elizabeth, Bergenstal, Richard, Coresh, Josef
Publicado em 2013

Recurrent Endocrine Cycles

Por Minor, James M., Rickey, Leslie M., Bergenstal, Richard M.
Publicado no J Diabetes Sci Technol (2016)

Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012

Por Selvin, Elizabeth, Parrinello, Christina M., Daya, Natalie, Bergenstal, Richard M.
Publicado no Diabetes Care (2016)

Can a Tool That Automates Insulin Titration Be a Key to Diabetes Management?

Por Bergenstal, Richard M., Bashan, Eran, McShane, Margaret, Johnson, Mary, Hodish, Israel
Publicado em 2012

No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes

Por Selvin, Elizabeth, Rawlings, Andreea M., Bergenstal, Richard M., Coresh, Josef, Brancati, Frederick L.
Publicado em 2013

Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial

Por Kelly, Aaron S, Bergenstal, Richard M, Gonzalez-Campoy, J Michael, Katz, Harold, Bank, Alan J
Publicado em 2012

Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)

Por Bergenstal, Richard M., Forti, Adriana, Chiasson, Jean-Louis, Woloschak, Michael, Boldrin, Mark, Balena, Raffaella
Publicado em 2012

Challenges and Future Directions of the T1D Exchange Clinic Network and Registry

Por Miller, Kellee M, Xing, Dongyuan, Tamborlane, William V, Bergenstal, Richard M., Beck, Roy W.
Publicado em 2013

A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project

Por Leite Silmara AO, Anderson Robyn L, Kendall David M, Monk Arlene M, Bergenstal Richard M
Publicado em 2009-09-01

A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project

Por Leite, Silmara AO, Anderson, Robyn L, Kendall, David M, Monk, Arlene M, Bergenstal, Richard M
Publicado em 2009

Low cardiorespiratory fitness in people at risk for type 2 diabetes: early marker for insulin resistance

Por Leite, Silmara AO, Monk, Arlene M, Upham, Paul A, Chacra, Antonio R, Bergenstal, Richard M
Publicado em 2009

Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Di...

Por Gough, Stephen C.L., Bhargava, Anuj, Jain, Rajeev, Mersebach, Henriette, Rasmussen, Søren, Bergenstal, Richard M.
Publicado em 2013

Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections

Por Foster, Nicole C., Miller, Kellee M., Tamborlane, William V., Bergenstal, Richard M., Beck, Roy W.
Publicado no Diabetes Care (2016)

Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine

Por Bergenstal, Richard M., Johnson, Mary, Powers, Margaret A., Wynne, Alan, Vlajnic, Aleksandra, Hollander, Priscilla, Rendell, Marc
Publicado em 2008

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

Por Drucker, Daniel J., Sherman, Steven I., Gorelick, Fred S., Bergenstal, Richard M., Sherwin, Robert S., Buse, John B.
Publicado em 2010

Application of PK/PD Modeling and Simulation to Dosing Regimen Optimization of High-Dose Human Regular U-500 Insulin

Por de la Peña, Amparo, Ma, Xiaosu, Reddy, Shobha, Ovalle, Fernando, Bergenstal, Richard M., Jackson, Jeffrey A.
Publicado no J Diabetes Sci Technol (2014)

Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia

Por Parrinello, Christina M., Sharrett, A. Richey, Maruthur, Nisa M., Bergenstal, Richard M., Grams, Morgan E., Coresh, Josef, Selvin, Elizabeth
Publicado no Diabetes Care (2016)

Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience

Por Buse, John B., Dailey, George, Ahmann, Andrew A., Bergenstal, Richard M., Green, Jennifer B., Peoples, Tim, Tanenberg, Robert J., Yang, Qingqing
Publicado em 2011

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes

Por Bergenstal, Richard M., Rosenstock, Julio, Arakaki, Richard F., Prince, Melvin J., Qu, Yongming, Sinha, Vikram P., Howey, Daniel C., Jacober, Scott J.
Publicado em 2012

Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treate...

Por Bergenstal, Richard M., Rosenstock, Julio, Arakaki, Richard F., Prince, Melvin J., Qu, Yongming, Sinha, Vikram P., Howey, Daniel C., Jacober, Scott J.
Publicado em 2013